Frequent Inactivation of Secreted Frizzled-Related Protein 2 during the Development of Cervical Carcinoma: Identification of Susceptible Alleles and Clinical Implications

Author:

Samadder Sudip1,Pal Debolina1,Roychowdhury Anirban12,Dutta Arindam34,Basu Mukta15,Dutta Sankhadeep1,Roy Anup6,Mandal Ranajit Kumar7,Roychoudhury Susanta3,Panda Chinmay Kumar1

Affiliation:

1. Department of Oncogene Regulation, Chittaranjan National Cancer Institute, West Bengal, Kolkata, India

2. Department of Internal Medicine, Division of Hematology, Oncology, and Palliative Care, Massey Cancer Center, Virginia Commonwealth University, Richmond, USA

3. Indian Institute of Chemical Biology IICB, West Bengal, Kolkata, India

4. Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD, USA

5. Department of Medicine, Hematology/ Oncology Division, Cedars Sinai Samuel Oschin Comprehensive Cancer Center, Los Angeles, CA, USA

6. Department of Pathology, Nil Ratan Sircar Medical College and Hospital, West Bengal, Kolkata, India

7. Department of Gynecologic Oncology, Chittaranjan National Cancer Institute, West Bengal, Kolkata, India

Abstract

ABSTRACT Background: In this study, importance of SFRP2, wnt stem cell renewal pathway antagonist, in the development of cervical cancer (CACX) was evaluated. Aims and Objectives: Alterations (expression/ methylation/ deletion) of SFRP2 were analysed in primary cervical lesions of different clinical stages followed by their correlation with different clinicopathological parameters. Then, susceptible allele(s) of SFRP2 was identified through case control study followed by and in vitro validation. Results: The mRNA expression of SFRP2 was gradually reduced with progression of CACX. In immunohistochemistry, SFRP2 membrane expression was mainly present in the spinous layers of normal cervical epithelium and its reduced protein expression in CACX samples showed concordance with mRNA expression. Frequent deletion/ methylation of SFRP2 were seen to be associated with development of cervical cancer. Methylation of SFRP2 was prevalently associated with early invasive lesions (stage I/II) while, deletion with late invasive lesions (stage III/IV). Overall alterations (deletion/ methylation) of SFRP2 were significantly increased from premalignant CIN to stage-I/II samples followed by comparable change to the next stage (stage III/IV) samples. Moreover, deletion and/or methylation of SFRP2 were associated with poor prognosis of the patients. In a case control study, out of its seven microsatellite alleles infrequent SFRP_CA15/16 alleles along with frequent SFRP_CA17 allelewere found to be associated with CACX development. Comparatively reduced expression (mRNA/ protein) of SFRP2 was seen in the tumor adjacent normal cervical epithelium having SFRP_CA15/16 alleles than the other alleles. This has been further validated in in vitro luciferase promoter activity assay where SFRP_CA16 repeat showed high reduced activity followed by SFRP_CA15 repeat than the other repeats. Conclusion: Thus, our data showed that presence of the infrequent susceptible alleles along with deletion/methylation might have synergistic effect on frequent inactivation of SFRP2 during development of CACX.

Publisher

Medknow

Reference24 articles.

1. Cancer statistics for the year 2020:An overview;Ferlay;Int J Cancer,2021

2. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation;Kombe Kombe;Front Public Health,2020

3. Epigenetic approaches for cervical neoplasia screening (review);Albulescu;Exp Ther Med,2021

4. Genomic alterations in cervical carcinoma:Losses of chromosome heterozygosity and human papilloma virus tumor status;Mullokandov;Cancer Res,1996

5. Deletions in chromosome 4 differentially associated with the development of cervical cancer:Evidence of slit2 as a candidate tumor suppressor gene;Singh;Hum Genet,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3